To enhance calcium silicate cements (CSCs) towards a specific clinical application of endodontics and vertebroplasty, the addition of oxide dopants (Bi2O3, SrO, ZnO, ZrO2) as radiopacifiers allows for tailoring of material properties.
OBJECTIVE:
Effects of oxide dopants on the in vitro physicochemical properties and osetogenic activity of CSCs were investigated.
METHODS:
The setting time, compressive strength, radiopacity, and osteogenic ability of the cements were evaluated. The ability of cement samples to support MG63 attachment, proliferation, differentiation, and mineralization was assessed.
RESULTS:
The greater the oxide amount, the higher the setting time and radiopacity were in the cement. The effect of the oxide dopants on radiopacity followed the order Bi2O3 > ZrO2 > SrO > ZnO, which were greater than 3 mm of Al recommended by ISO 6876: 2001 standards. ZrO2 could reinforce compressive strength of the control cement, while ZnO remarkably reduced the strength. The adverse effect of Bi2O3 and ZrO2 was found on cell number, alkaline phosphatase (ALP) activity and mineralization of MG63 cells. SrO supported cell attachment, proliferation and differentiation, and significantly increased cellular mineralization compared to the control.
CONCLUSIONS:
The 20 wt% SrO-containing CSCs may be applied to endodontic treatment and vertebroplasty surgery.
CamilleriJ., The physical properties of accelerated Portland cement for endodontic use, Int. Endod. J.41 (2008), 151–157.
2.
LinQ.ZhangW.LuC.HouG. and XuZ., In vivo investigation of biological responses to tricalcium silicate pastes in muscle tissue, Ceram. Int.40 (2014), 1879–1883.
3.
WuB.C.WeiC.K.HsuehN.S. and DingS.J., Comparative cell attachment, cytotoxicity and antibacterial activity of radiopaque dicalcium silicate cement and white-coloured mineral trioxide aggregate, Int. Endod. J.48 (2015), 268–276.
4.
WeiC.K. and DingS.J., Acid-resistant calcium silicate-based composite implants with high-strength as load-bearing bone graft substitutes and fracture fixation devices, J. Mech. Behav. Biomed. Mater.62 (2016), 366–383.
5.
XuS.LinK.WangZ.ChangJ.WangL.LuJ. and NingC., Reconstruction ofcalvarial defect of rabbits using porous calcium silicate bioactive ceramics, Biomaterials29 (2008), 2588–2596.
6.
WuB.C.HuangS.C. and DingS.J., Comparative osteogenesis of radiopaque dicalcium silicate cement and white-colored mineral trioxide aggregate in a rabbit femur model, Materials6 (2013), 5675–5689.
7.
SugawaraA.AsaokaK. and DingS.J., Calcium phosphate-based cements: Clinical needs and recent progress, J. Mater. Chem. B1 (2013), 1081–1089.
8.
CoomaraswamyK.S.LumleyP.J. and HofmannM.P., Effect of bismuth oxide radioopacifier content on the material properties of an endodontic Portland cement-based (MTA-like) system, J. Endod.33 (2007), 295–298.
9.
Hungaro DuarteM.A.de Oliveira El KadreG.D.VivanR.R.Guerreiro TanomaruJ.M.Tanomaru FilhoM. and de MoraesI.G., Radiopacity of portland cement associated with different radiopacifying agents, J. Endod.35 (2009), 737–740.
10.
ChiangT.Y.WeiC.K. and DingS.J., Effects of bismuth oxide on physicochemical properties and osteogenic activity of dicalcium silicate cements, J. Med. Biol. Eng.34 (2014), 30–35.
11.
OvesenJ.Moller-MadsenB.ThomsenJ.S.DanscherG. and MosekildeL., The positive effects of zinc on skeletal strength in growing rats, Bone29 (2001), 565–570.
12.
AtkinsonI.AnghelE.M.PredoanaL.MocioiuO.C.JecuL.RautI.MunteanuC.CulitaD. and ZaharescuM., Influence of ZnO addition on the structural, in vitro behavior and antimicrobial activity of sol–gel derived CaO– P2O5–SiO2 bioactive glasses, Ceram. Int.42 (2016), 3033–3045.
13.
WuC.C.WeiC.K.HoC.C. and DingS.J., Enhanced hydrophilicity and biocompatibility of dental zirconia ceramics by oxygen plasma treatment, Materials8 (2015), 684–699.
14.
SilvaG.F.BossoR.FerinoR.V.Tanomaru-FilhoM.BernardiM.I.B.Guerreiro-TanomaruJ.M. and CerriP.S., Microparticulated and nanoparticulated zirconium oxide added to calcium silicate cement: Evaluation of physicochemical and biological properties, J. Biomed. Mater. Res. A102 (2014), 4336–4345.
15.
SkorynaS., Metabolic aspects of the pharmacologic uses of the trace elements in human subjects with specific reference to stable strontium, Trace Subst. Environ. Health18 (1984), 3–23.
16.
ZhangY.WeiL.ChangJ.MironR.J.ShiB.YiS. and WuC., Strontium-incorporated mesoporous bioactive glass scaffolds stimulating in vitro proliferation and differentiation of bone marrow stromal cells and in vivo regeneration of osteoporotic bone defects, J. Mater. Chem. B1 (2013), 5711–5722.
17.
LinK.WangX.ZhangN. and ShenY., Strontium (Sr) strengthens the silicon (Si) upon osteoblast proliferation, osteogenic differentiation and angiogenic factor expression, J. Mater. Chem. B4 (2016), 3632–3638.
18.
WangX.YeJ. and WangY., Influence of a novel radiopacifier on the properties of an injectable calcium phosphate cement, Acta Biomater.3 (2007), 757–763.
19.
WeiC.K. and DingS.J., Dual-functional bone implants with antibacterial ability and osteogenic activity, J. Mater. Chem. B5 (2017), 1943–1953.
20.
ChenC.C.HoC.C.LinS.Y. and DingS.J., Green synthesis of calcium silicate bioceramic powders, Ceram. Int.41 (2015), 5445–5453.
21.
CamilleriJ. and GandolfiM.G., Evaluation of the radiopacity of calcium silicate cements containing different radiopacifiers, Int. Endod. J.43 (2010), 21–30.
22.
CamilleriJ., Hydration mechanisms of mineral trioxide aggregate, Int. Endod. J.40 (2007), 462–470.
23.
BortoluzziE.A.Guerreiro-TanomaruJ.M.Tanomaru-FilhoM. and DuarteM.A.H., Radiographic effect of different radiopacifiers on a potential retrograde filling material, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.108 (2009), 628–632.
24.
Tanomaru-FilhoM.da SilvaG.F.DuarteM.A.H.GonçalvesM. and TanomaruJ.M.G., Radiopacity evaluation of root-end filling materials by digitization of images, J. Appl. Oral Sci.16 (2008), 376–379.
25.
BodrumluE. and GungorK., Radiopacity of an endodontic core material, Am. J. Dent.22 (2009), 157–159.
26.
CamilleriJ.CutajarA. and MalliaB., Hydration characteristics of zirconium oxide replaced Portland cement for use as a rootend filling material, Dent. Mater.27 (2011), 845–854.
27.
CamilleriJ.MontesinF.E.PapaioannouS.McDonaldF. and FordT.R.P., Biocompatibility of two commercial forms of mineral trioxide aggregate, Int. Endod. J.37 (2004), 699–704.
28.
AnselmeK., Osteoblast adhesion on biomaterials, Biomaterials21 (2000), 667–681.
29.
DingS.J.ChuY.H. and WangD.Y., Enhanced properties of novel zirconia-based osteo-implant systems, Appl. Mater. Today9 (2017), 622–632.
30.
WongC.T.LuW.W.ChanW.K.CheungK.M.C.LukK.D.K.LuD.S.RabieA.B.M.DengL.F. and LeongJ.C.Y., In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (Sr-HA) bioactive cement, J. Biomed. Mater. Res. A68 (2004), 513–521.
